Fei Xu1, Fangtian Dong, Hui Li, Xin Li, Ruxin Jiang, Ruifang Sui. 1. Department of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Shuai Fu Yuan, Beijing 100730, China.
Abstract
BACKGROUND: This study aimed to evaluate the clinical phenotype and investigate the molecular genetic defect in a Chinese family with autosomal dominant cone-rod dystrophy (ADCRD). METHODS: Family history was collected and patients underwent regular ophthalmologic examinations. Two affected individuals underwent three-year follow-ups to analyze the course of the disease. Venous blood was collected from family members and genomic DNA was extracted. A whole genome linkage analysis of 11 family members was performed using an Illumina Infinium Human Linkage-12 panel. All exons and exon-intron boundaries of guanylate cyclase 2D gene (GUCY2D) were sequenced for familial gene mutation. RESULTS: Decreased visual acuity and photophobia usually commenced in early childhood in these patients. The family demonstrated an age-dependent increase in macular abnormalities with progressive development of geographic atrophy. Electrophysiological testing revealed a marked loss of cone function. Initially, a genome-wide linkage analysis mapped the disease to chromosome 17 (1-36 cM), with a maximum LOD score of 1.505. Sequence analysis of the GUCY2D gene in the linkage interval detected a recurrent heterozygous mutation, c.2513G > C (p.R838P). This mutation appeared in all seven patients with ADCRD but did not appear in any of the four unaffected family members. CONCLUSIONS: A missense mutation in the GUCY2D gene caused ADCRD in this family. Clinical follow-up of this family with a typical CRD phenotype revealed disease progression during the time period.
BACKGROUND: This study aimed to evaluate the clinical phenotype and investigate the molecular genetic defect in a Chinese family with autosomal dominant cone-rod dystrophy (ADCRD). METHODS: Family history was collected and patients underwent regular ophthalmologic examinations. Two affected individuals underwent three-year follow-ups to analyze the course of the disease. Venous blood was collected from family members and genomic DNA was extracted. A whole genome linkage analysis of 11 family members was performed using an Illumina Infinium Human Linkage-12 panel. All exons and exon-intron boundaries of guanylate cyclase 2D gene (GUCY2D) were sequenced for familial gene mutation. RESULTS:Decreased visual acuity and photophobia usually commenced in early childhood in these patients. The family demonstrated an age-dependent increase in macular abnormalities with progressive development of geographic atrophy. Electrophysiological testing revealed a marked loss of cone function. Initially, a genome-wide linkage analysis mapped the disease to chromosome 17 (1-36 cM), with a maximum LOD score of 1.505. Sequence analysis of the GUCY2D gene in the linkage interval detected a recurrent heterozygous mutation, c.2513G > C (p.R838P). This mutation appeared in all seven patients with ADCRD but did not appear in any of the four unaffected family members. CONCLUSIONS: A missense mutation in the GUCY2D gene caused ADCRD in this family. Clinical follow-up of this family with a typical CRD phenotype revealed disease progression during the time period.
Authors: I Perrault; J M Rozet; S Gerber; I Ghazi; D Ducroq; E Souied; C Leowski; M Bonnemaison; J L Dufier; A Munnich; J Kaplan Journal: Eur J Hum Genet Date: 2000-08 Impact factor: 4.246
Authors: I Perrault; J M Rozet; S Gerber; R E Kelsell; E Souied; A Cabot; D M Hunt; A Munnich; J Kaplan Journal: Am J Hum Genet Date: 1998-08 Impact factor: 11.025
Authors: S E Wilkie; R J Newbold; E Deery; C E Walker; I Stinton; V Ramamurthy; J B Hurley; S S Bhattacharya; M J Warren; D M Hunt Journal: Hum Mol Genet Date: 2000-12-12 Impact factor: 6.150
Authors: Veronique B D Kitiratschky; Robert Wilke; Agnes B Renner; Ulrich Kellner; Maria Vadalà; David G Birch; Bernd Wissinger; Eberhart Zrenner; Susanne Kohl Journal: Invest Ophthalmol Vis Sci Date: 2008-05-16 Impact factor: 4.799
Authors: Camiel J F Boon; B Jeroen Klevering; Frans P M Cremers; Marijke N Zonneveld-Vrieling; Thomas Theelen; Anneke I Den Hollander; Carel B Hoyng Journal: Ophthalmology Date: 2009-02-25 Impact factor: 12.079
Authors: Frederick T Collison; Gerald A Fishman; Takayuki Nagasaki; Jana Zernant; J Jason McAnany; Jason C Park; Rando Allikmets Journal: Invest Ophthalmol Vis Sci Date: 2019-05-01 Impact factor: 4.799